CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 159 filers reported holding CONSTELLATION PHARMCETICLS I in Q2 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,689,000 | +56.0% | 49,985 | +8.0% | 0.00% | +100.0% |
| Q1 2021 | $1,083,000 | -19.1% | 46,283 | -0.5% | 0.00% | -50.0% |
| Q4 2020 | $1,339,000 | +42.1% | 46,497 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $942,000 | -23.1% | 46,497 | +14.1% | 0.00% | 0.0% |
| Q2 2020 | $1,225,000 | +35.7% | 40,760 | +41.9% | 0.00% | 0.0% |
| Q1 2020 | $903,000 | -18.8% | 28,731 | +21.7% | 0.00% | 0.0% |
| Q4 2019 | $1,112,000 | +622.1% | 23,609 | -0.8% | 0.00% | – |
| Q3 2019 | $154,000 | -47.3% | 23,799 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $292,000 | -12.0% | 23,799 | -3.0% | 0.00% | 0.0% |
| Q1 2019 | $332,000 | +1283.3% | 24,538 | +302.1% | 0.00% | – |
| Q4 2018 | $24,000 | -41.5% | 6,102 | 0.0% | 0.00% | – |
| Q3 2018 | $41,000 | – | 6,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
| Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
| VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
| Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
| Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
| GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
| Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
| COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
| Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |